FOLLICULAR MORPHOGENESIS DURING PERINATAL DEVELOPMENT
Project Number5R01HD038468-04
Contact PI/Project LeaderROY, SHYAMAL K
Awardee OrganizationUNIVERSITY OF NEBRASKA MEDICAL CENTER
Description
Abstract Text
The mechanisms regulating the onset of follicular morphogenesis remain unresolved, but the differentiation of granulosa cells from pluripotential somatic cells and their interaction with oocytes appears to be an essential early step. In contrast to rats and mice, ovaries of newborn Syrian hamsters contain oocytes in the 1st meiotic prophase, and undifferentiated somatic cells. Therefore, we have an ideal animal model for studying the mechanism involved in producing the first cohort of follicles. Preliminary studies have shown that: [1] immunoinactivation of endogenous FSH results in nearly complete inhibition of primordial follicle formation and this can be reversed by equine chorionic gonadotropin (eCG), a hormone with FSH activity unaffected by the highly specific anti-FSH serum; [2] the failure of follicular formation is correlated with an appreciable reduction in the transcription and translation of the epidermal growth factor (EGF) receptor gene consistent with our earlier findings that FSH functions via EGF and its receptor; [3] exposure of neonatal ovaries in vivo or in vitro to eCG upregulates the expression of EGF, EGF-receptor and TGF-beta receptor associated with accelerated granulosa cell and follicle differentiation and [4] increased expression of FSH-receptor mRNA correlates with increased FSH function. We hypothesize that FSH controls the differentiation of pluripotential somatic cells into granulosa cells during the first phases of follicular morphogenesis by mechanisms that involve the spatio-temporal interaction of EGF and TGF-beta receptors with their appropriate ligands. This will be tested in vivo using anti-FSH antiserum and in vitro using fetal and early postnatal hamster ovaries exposed to FSH and/or growth factors. Measured parameters include [1] morphometric quantitation of follicle formation; [2] quantitative evaluation by Western immunoblotting, of the significance of EGF and TGF-beta ligand and receptor expression during granulosa cell differentiation; their cell- specific subtle expression will be identified by immunofluorescence; [3] correlation of changes in EGF and TGF-beta receptor mRNA, determined by RT-PCR quantitation, with gonadotropin-regulated differentiation and [4] measurement of ovarian steroidogenic activity to determine the functional significance of follicular development following in vitro hormone and/or growth factor manipulation. Results will contribute substantially to our understanding of the mechanisms involved in the initial steps of folliculogenesis, i.e., the formation of primordial follicles, which will prove valuable for improving the treatment and management of human infertility.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
168559177
UEI
G15AG3BLLMH4
Project Start Date
01-July-2001
Project End Date
30-June-2006
Budget Start Date
01-July-2004
Budget End Date
30-June-2006
Project Funding Information for 2004
Total Funding
$257,250
Direct Costs
$175,000
Indirect Costs
$82,250
Year
Funding IC
FY Total Cost by IC
2004
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$257,250
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01HD038468-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HD038468-04
Patents
No Patents information available for 5R01HD038468-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HD038468-04
Clinical Studies
No Clinical Studies information available for 5R01HD038468-04
News and More
Related News Releases
No news release information available for 5R01HD038468-04
History
No Historical information available for 5R01HD038468-04
Similar Projects
No Similar Projects information available for 5R01HD038468-04